# Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C)

Source: https://onco.cc/trials/nct04956640/  
OnCo record `nct04956640` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 1/2 trial of Olomorasib, Pembrolizumab, Cetuximab, Pemetrexed, Cisplatin and Carboplatin in non-small-cell lung cancer, colorectal cancer, endometrial cancer, ovarian cancer, pancreatic ductal adenocarcinoma and biliary tract cancer, run by Eli Lilly and Company, active and no longer recruiting.

## Summary

Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C) is a phase 1/2 interventional study registered as NCT04956640 by Eli Lilly and Company, with 540 participants enrolled, started 2021-07-19 and due to reach its primary completion in 2027-04. Interventions recorded: LY3537982, Pembrolizumab, Cetuximab, Pemetrexed, Cisplatin and Carboplatin.

## Fields

- Kind: Trial
- Status: active
- Last checked: 2026-09-16
- Tags: pipeline; ctgov-ingest
- Registry id: NCT04956640
- Phase: 1/2
- Setting: A Phase 1/2 Study of LY3537982 in Patients With KRAS G12C-Mutant Advanced Solid Tumors
- Sponsor: Eli Lilly and Company
- Enrolled: 540

## Sources

- ClinicalTrials.gov NCT04956640: https://clinicaltrials.gov/study/NCT04956640

## Connected records

- cancers: [Biliary tract cancer (cholangiocarcinoma)](https://onco.cc/cancers/cholangiocarcinoma/), [Colorectal cancer](https://onco.cc/cancers/colorectal/), [Endometrial cancer](https://onco.cc/cancers/endometrial/), [Non-small-cell lung cancer](https://onco.cc/cancers/nsclc/), [Ovarian cancer](https://onco.cc/cancers/ovarian/), [Pancreatic ductal adenocarcinoma](https://onco.cc/cancers/pancreatic/)
- drugs: [Carboplatin](https://onco.cc/drugs/carboplatin/), [Cetuximab](https://onco.cc/drugs/cetuximab/), [Cisplatin](https://onco.cc/drugs/cisplatin/), [Olomorasib](https://onco.cc/drugs/olomorasib/), [Pembrolizumab](https://onco.cc/drugs/pembrolizumab/), [Pemetrexed](https://onco.cc/drugs/pemetrexed/)
- companies: [Eli Lilly (incl. Loxo)](https://onco.cc/companies/eli-lilly/), [Merck & Co. (MSD)](https://onco.cc/companies/merck/)

---
JSON: https://onco.cc/api/v1/entities/nct04956640.json